Hematology & Oncology Doctors in Saint Cloud, MN Accepting Medicare

2 Hematology & Oncology doctors found. Showing 1 - 2

Donald James Jurgens, M.D. Internal Medicine - Hematology & Oncology Medicare: May Accept Medicare Assignments Practice Location: 1900 Centracare Cir, Centracare Clinic Health Plaza Specialties, Saint Cloud, MN 56303 Phone: 320-229-4907    Fax: 320-229-5160

Nicholas F Reuter, MD Internal Medicine - Hematology & Oncology Medicare: Medicare Enrolled Practice Location: 1900 Centracare Cir, Saint Cloud, MN 56303 Phone: 320-229-4902    Fax: 320-229-5160

News Archive

KLAS survey reveals client confidence in athenaClinicals EHR

athenahealth, Inc., a leading provider of internet-based business services to physician practices, today announced that according to a new KLAS report Ambulatory EMR: On Track for Meaningful Use?, athenaClinicalsSM, the Company's web-based electronic health record (EHR) service offering, achieved 100% client confidence in its ability to enable them to meet 2011 Meaningful Use standards under the HITECH Act.

Enzon to discontinue PEG-SN38 clinical program in metastatic colorectal cancer

Enzon Pharmaceuticals, Inc. today announced that, in light of evolving standards of care for the treatment of metastatic colorectal cancer (mCRC), the Company will discontinue its PEG-SN38 (EZN-2208) clinical program in this disease, following conclusion of its Phase II study.

Impact of the patient centered medical home model on the health care reform

Health2 Resources announced today free access to its Web portal, H2RMinutes, a one-stop source for news about the patient centered medical home (PCMH). H2RMinutes (http://www.h2rminutes.com) is designed specifically to keep health care policymakers, providers, employers and suppliers informed about the impact that the PCMH model is having on the national health care reform debate.

Local clinical quality monitoring for detection of excess operative deaths

If convicted murderer Dr Harold Shipman had been working as a surgeon or anaesthetist at a specialist UK heart hospital in Cambridge, increased patient death rates would have alerted clinical audit staff after eight to ten months, according to research in the latest issue of Anaesthesia.

Genetic lab test for Warfarin sensitivity approved by FDA

The U.S. Food and Drug Administration today cleared for marketing a new genetic test that will help physicians assess whether a patient may be especially sensitive to the blood-thinning drug warfarin (Coumadin), which is used to prevent potentially fatal clots in blood vessels.

Read more Medical News

› Verified 1 days ago